Yuhan Corporation (KRX:000100)
South Korea · Delayed Price · Currency is KRW 125,000
+3,800 (3.14%)
Last updated: Nov 17, 2025, 9:11 AM KST
Yuhan Market Cap
Yuhan has a market cap or net worth of 9.35 trillion as of November 14, 2025. Its market cap has decreased by -19.53% in one year.
Market Cap
9.35T
Enterprise Value
9.41T
Revenue
2.17T
Ranking
n/a
PE Ratio
124.21
Stock Price
125,000.00
Market Cap Chart
Since April 26, 2001, Yuhan's market cap has increased from 231.73B to 9.35T, an increase of 3,936.50%. That is a compound annual growth rate of 16.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 14, 2025 | 9.35T | 4.59% |
| Dec 30, 2024 | 8.94T | 73.59% |
| Dec 28, 2023 | 5.15T | 25.86% |
| Dec 29, 2022 | 4.09T | -3.94% |
| Dec 30, 2021 | 4.26T | -9.20% |
| Dec 30, 2020 | 4.69T | 58.97% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 86.90T |
| Celltrion | 43.20T |
| ALTEOGEN | 29.63T |
| SK Biopharmaceuticals | 10.05T |
| ABL Bio | 9.60T |
| Peptron | 7.22T |
| HLB Co., Ltd. | 6.50T |
| LigaChem Biosciences | 6.39T |